Rapid, point-of-care, low-cost aneuploidy screening using a handheld nanopore-based DNA sequencer

Unmet Medical Need:  Testing for aneuploidy (the presence of an abnormal number of chromosomes) is an integral part of fertility and prenatal care. Current technologies for testing are expensive, slow, and requires that specimens be sent to centralized high-complexity lab. There is a need for an efficient, point-of-care screening tool for aneuploidy.

Envisioned Healthcare Product: A rapid, low cost, point-of-care aneuploidy testing using disposable, hand-held nanopore-based DNA sequencing.

Stage of Development:  Validation

January 2016 Article

May 2018 Article

October 2018 Update

Collaborative Research Team:  Zev Williams, MD, PhD and Shan Wei


Funding Cycle: 2019-2020